| Primary |
| Isolated Adrenocorticotropic Hormone Deficiency |
16.9% |
| Hypopituitarism |
15.5% |
| Adrenal Insufficiency |
14.1% |
| Pituitary Tumour Benign |
7.0% |
| Adrenogenital Syndrome |
4.2% |
| Hypothyroidism |
4.2% |
| Prophylaxis |
4.2% |
| Addison's Disease |
2.8% |
| Deafness Neurosensory |
2.8% |
| Disseminated Intravascular Coagulation |
2.8% |
| Electrolyte Imbalance |
2.8% |
| Histiocytosis Haematophagic |
2.8% |
| Hormone Replacement Therapy |
2.8% |
| Ill-defined Disorder |
2.8% |
| Lower Respiratory Tract Infection |
2.8% |
| Lung Neoplasm Malignant |
2.8% |
| Prostatic Disorder |
2.8% |
| Pseudomonas Infection |
2.8% |
| Acth Abnormal |
1.4% |
| Adrenalectomy |
1.4% |
|
| Hallucination, Visual |
8.5% |
| Pyrexia |
8.5% |
| Diabetes Insipidus |
6.4% |
| Hypoglycaemia |
6.4% |
| Hypotension |
6.4% |
| Pneumonia |
6.4% |
| Psychiatric Symptom |
6.4% |
| Adrenocortical Insufficiency Acute |
4.3% |
| Electrolyte Depletion |
4.3% |
| General Physical Health Deterioration |
4.3% |
| Hypomania |
4.3% |
| Lymphocytic Hypophysitis |
4.3% |
| Metabolic Acidosis |
4.3% |
| Pancytopenia |
4.3% |
| Polyuria |
4.3% |
| Renal Impairment |
4.3% |
| Uterine Haemorrhage |
4.3% |
| Uveitis |
4.3% |
| Amenorrhoea |
2.1% |
| Aphagia |
2.1% |
|
| Secondary |
| Myocardial Infarction |
26.5% |
| Drug Use For Unknown Indication |
21.3% |
| Hypopituitarism |
8.8% |
| Cerebral Atrophy |
8.1% |
| Asthma |
5.9% |
| Isolated Adrenocorticotropic Hormone Deficiency |
5.9% |
| Adrenal Insufficiency |
3.7% |
| Upper Respiratory Tract Infection |
2.9% |
| Anaplastic Astrocytoma |
2.2% |
| Brain Oedema |
1.5% |
| Deafness Neurosensory |
1.5% |
| Dementia |
1.5% |
| Glioblastoma Multiforme |
1.5% |
| Hyponatraemia |
1.5% |
| Influenza |
1.5% |
| Juvenile Arthritis |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Pyrexia |
1.5% |
| Acth Abnormal |
0.7% |
| Atrophy |
0.7% |
|
| Hyponatraemia |
11.4% |
| Herpes Zoster |
8.6% |
| Hypomania |
8.6% |
| Lymphocytic Hypophysitis |
8.6% |
| Pyrexia |
8.6% |
| Decreased Appetite |
5.7% |
| Gamma-glutamyltransferase Increased |
5.7% |
| Polyuria |
5.7% |
| Therapeutic Response Delayed |
5.7% |
| Accidental Overdose |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Diabetes Insipidus |
2.9% |
| Dysphagia |
2.9% |
| Fracture |
2.9% |
| Hyperlipidaemia |
2.9% |
| Hypoalbuminaemia |
2.9% |
| Hypoglycaemia |
2.9% |
| Hypopituitarism |
2.9% |
| Localised Oedema |
2.9% |
| Mononeuritis |
2.9% |
|
| Concomitant |
| Prophylaxis |
15.9% |
| Hypertension |
11.3% |
| Hypopituitarism |
8.3% |
| Graft Versus Host Disease |
7.0% |
| Growth Hormone Deficiency |
6.9% |
| Psoriasis |
6.6% |
| Adrenal Insufficiency |
4.8% |
| Metastatic Renal Cell Carcinoma |
4.3% |
| Hypothyroidism |
3.6% |
| Drug Use For Unknown Indication |
3.4% |
| Secondary Hypothyroidism |
3.4% |
| Multiple Myeloma |
3.4% |
| Insomnia |
3.1% |
| Gastritis Prophylaxis |
2.8% |
| Gastritis |
2.7% |
| Steroid Therapy |
2.6% |
| Cardiac Failure |
2.4% |
| Constipation |
2.4% |
| Mineral Supplementation |
2.4% |
| Hiv Infection |
2.4% |
|
| Neoplasm Recurrence |
8.0% |
| Rhabdomyolysis |
8.0% |
| White Blood Cell Count Decreased |
8.0% |
| White Blood Cell Count Increased |
6.3% |
| Craniopharyngioma |
5.7% |
| Pituitary Tumour Benign |
5.7% |
| Vomiting |
5.7% |
| Adrenal Insufficiency |
5.1% |
| Germ Cell Cancer |
5.1% |
| Pyrexia |
5.1% |
| Multi-organ Failure |
4.5% |
| Sepsis |
4.5% |
| Somnolence |
4.5% |
| Convulsion |
3.4% |
| Death |
3.4% |
| Rash |
3.4% |
| Renal Cell Carcinoma |
3.4% |
| Renal Failure |
3.4% |
| Restlessness |
3.4% |
| Stomatitis |
3.4% |
|
| Interacting |
| Hypopituitarism |
66.7% |
| Type 2 Diabetes Mellitus |
33.3% |
|
|
